YME1L1 and Atrophy: Patients carrying mutations in YME1L1 present with optic atrophy-11 (OPA11, MIM #617302), characterized by intellectual disabilities, muscular degradation and optic nerve atrophy, associated with abnormal OPA1 processing and mitochondrial fragmentation [88].